Merck Serono, a division of the German giant Merck, is investing at least 10 million euros in a project to grow Israeli biotech companies. Israeli start-ups can use Merck’s R&D InterLab facilities in Yavneh for research in order to bring new drugs to market.
http://www.timesofisrael.com/pharma-giant-merck-serono-invests-in-israeli-biotech-incubator/